feed,title,long_url,short_url
Benzinga,FDA Says Travere's Sparsentan Data Not Sufficient For Accelerated Approval In One Indication,https://benzinga.com/general/biotech/22/08/28348603/fda-says-traveres-sparsentan-data-not-sufficient-for-accelerated-approval-in-one-indication,https://bit.ly/3oUCSF6
